Precise treatment with light and oxygen 

How does photodynamic therapy work? 

A photosensitizing substance is administered to the patient in the form of a cream, gel, or intravenously. This substance accumulates primarily in pathologically altered tissues. The affected area is then irradiated with light of a strictly defined wavelength. In the presence of oxygen, reactive oxygen species are generated—highly active molecules that destroy diseased cells or microorganisms while sparing healthy tissues. 

As emphasized by Dr. Aneta Popiel-Kopaczyk from the Division of Histology and Embryology, Department of Human Morphology and Embryology at Wroclaw Medical University, it is precisely this selectivity that determines the strength of this technology. 

-Photodynamic therapy involves administering a photosensitizing substance to the patient, which accumulates in tissues that are particularly pathologically altered. After activation by light, it generates reactive oxygen species that damage infected or neoplastic tissues, the researcher explains.

The most significant changes in the perception of photodynamic therapy currently concern non-oncological fields. Particular hopes are associated with photodynamic antimicrobial chemotherapy. This method uses light to combat bacteria, fungi, and viruses, including those resistant to antibiotics. Unlike classical drugs, it does not act on a single specific microbial mechanism but induces strong oxidative stress, which leads to the destruction of pathogens.

-Photodynamic antimicrobial chemotherapy has enormous potential to become an adjunct therapy to antibiotic treatment—reducing bacterial load and biofilm and increasing treatment effectiveness,emphasizes Dr. Popiel-Kopaczyk. -This is particularly important in the context of the growing resistance of bacteria to drugs and the risks this poses for children, she adds. 

A close up of a red firework on a black background

Photo by Nastia Petruk on Unsplash

Photo by Nastia Petruk on Unsplash

Image credit: CDC/ Rodney M. Donlan, Ph.D.; Janice Carr (PHIL #7488), 2005. Obtained from the CDC Public Health Image Library.

Image credit: CDC/ Rodney M. Donlan, Ph.D.; Janice Carr (PHIL #7488), 2005. Obtained from the CDC Public Health Image Library.

Biofilm 

One of the main reasons why infection treatment is often ineffective is biofilm—a protective structure formed by bacteria. Instead of occurring individually, microorganisms form organized colonies and surround themselves with a layer of substances that acts as a biological shield. Such a biofilm impedes antibiotic penetration and protects bacteria from the immune system, leading to chronic infections that are prone to recurrence. 

Photodynamic therapy works differently from classical drugs. Under light exposure, it produces reactive oxygen species that simultaneously damage bacteria and disrupt the biofilm structure. As a result, this method can be effective where antibiotics fail—especially in chronic and localized infections, including in patients with conditions such as cystic fibrosis. As emphasized by Dr. Aneta Popiel-Kopaczyk, the ability to break down biofilm is one of the greatest advantages of photodynamic antimicrobial chemotherapy, although its broader application is still limited by technical issues related to light delivery and procedure standardization. 

Podcast: The Science of Photodynamic Precision Medicine

Polymeric nanocarriers 

A true breakthrough in the development of photodynamic therapy has been the use of polymeric nanocarriers—microscopic structures that act as intelligent “packages” for photosensitizing substances. It is largely they who determine whether therapy will be not only effective but, above all, safe for the patient. Encapsulation of the photosensitizer within a nanocarrier protects it from premature degradation in the body, prolongs its circulation time, and ensures that the drug reaches pathologically altered tissues to a greater extent than healthy organs. 

A key advantage of nanocarriers is the possibility of “controlling” therapy at the molecular level. By selecting appropriate polymeric materials, it is possible to regulate the release rate of the photosensitizing substance and even ensure it is activated only under specific conditions—for example, at a defined pH or upon reaching diseased tissue. In practice, this means greater control over treatment and a lower risk of adverse effects, such as damage to healthy cells or photosensitivity. 

As emphasized by Dr. Aneta Popiel-Kopaczyk, increased selectivity is currently of the greatest clinical importance. 

-The greatest clinical significance lies in increased selectivity and, consequently, the safety of therapy, the researcher notes. 
-By modifying nanocarriers, for example, by attaching antibodies, we can direct the photosensitizing substance very precisely to pathologically altered sites. 

Such “active targeting” of the drug means that the nanocarrier recognizes specific features of diseased cells—for example, the presence of particular proteins or receptors—and delivers the photosensitizing agent precisely to those cells. This represents a major qualitative change compared to classical treatment methods, in which drugs often act broadly and non-selectively. In photodynamic therapy using nanocarriers, one can even speak of ultra-precise targeting of the therapeutic goal. 

The importance of this solution is particularly evident in the context of treating children and chronic diseases, where treatment safety is of key importance. Limiting exposure of healthy tissues to active substances reduces the risk of complications and allows photodynamic therapy to be considered a realistically suitable method for long-term use. At the same time, nanocarriers open the door to combination therapies—in the future, they may transport not only photosensitizing agents but also other drugs or molecules that support treatment. 

What limits the wider use of this method? 

Despite the dynamic development of technology and the growing number of studies, photodynamic therapy has not yet become a standard in many fields of medicine. This is not due to a lack of effectiveness, but rather to difficulties in implementing it in a repeatable and comparable manner across different centers. The greatest challenge remains the lack of uniform treatment standards and precise control of the therapeutic dose. Unlike classical drugs, whose doses can be clearly defined in milligrams, the effectiveness of photodynamic therapy depends on the simultaneous interaction of multiple factors. 

As emphasized by Dr. Aneta Popiel-Kopaczyk, this method requires control of three key variables: the amount of light reaching the tissues, the dose of the applied photosensitizing substance, and the availability of oxygen at the treatment site. 

-It is necessary to move from an effective method that is highly dependent on the experience of the operator to a repeatable clinical standard, the researcher notes. 
-Only then will it be possible to compare treatment outcomes, formulate strong recommendations, and implement this method more broadly, including in the treatment of children

An additional limitation, especially in antimicrobial applications, is the delivery of light to hard-to-reach areas, such as deep tissues or regions covered with biofilm. This requires not only advanced equipment but also well-designed protocols and appropriate training of medical personnel. 

Although photodynamic therapy is sometimes perceived as a method of the future, it is already used in clinical practice, also in Poland. It is used, among other applications, in fluorescence diagnostics and in the treatment of dental infections. This shows that the problem is not the technology itself or a lack of scientific evidence, but rather the scale of its implementation. 

The wider adoption of photodynamic therapy primarily requires the development of clear standards of practice, access to modern equipment, and systematic training of specialists. Equally important is educating physicians and patients about the mechanism of action of this method and its real clinical benefits. If these conditions are met, light-based treatment may become one of the pillars of modern medicine: effective, precise, and significantly less burdensome for patients than many currently used therapies. 

A.Hasiak

FAQ – Frequently Asked Questions about Photodynamic Therapy 

Is photodynamic therapy safe?

 Yes. Photodynamic therapy is considered a minimally invasive and safe method because it acts locally and selectively. The photosensitizing substance is activated only where light is applied, which limits the risk of damage to healthy tissues and systemic side effects. 

Is photodynamic therapy painful?

In most patients, the procedure is associated only with mild discomfort, such as warmth, burning, or tingling at the site of irradiation. These symptoms are usually short-lived and subside after the procedure is completed.

How does photodynamic therapy differ from antibiotics?

Antibiotics act on specific processes in bacterial cells, which allows microorganisms to develop resistance over time. Photodynamic therapy uses light and oxygen to generate reactive oxygen species that destroy bacteria and biofilm mechanically and chemically. As a result, the risk of developing resistance is significantly lower.

In which diseases is photodynamic therapy currently used?

It is currently used, among other applications, in the treatment of selected skin cancers, in dermatology and dentistry, and in fluorescence diagnostics. Its applications in the treatment of chronic infections, inflammatory diseases, and selected pediatric conditions are also being intensively studied. 

Why is photodynamic therapy not yet a widespread standard?

The main barrier is not a lack of effectiveness, but difficulty in standardizing procedures. Treatment effectiveness depends simultaneously on the amount of light, the dose of the photosensitizing substance, and oxygen availability. Only the development of uniform protocols and precise control of these parameters will allow wider implementation of the method.

Does photodynamic therapy replace other treatment methods? 

Most often, it does not replace but complements standard treatment. It can support the action of antibiotics, reduce microbial load, or improve the effectiveness of other therapies, especially where classical methods are insufficient. 

What is the availability of photodynamic therapy in Poland? 

The method is already used in selected centers, including dentistry and fluorescence diagnostics. Its wider implementation depends on the development of standards of practice, the availability of equipment, and the training of medical personnel. 

Powerd by NotebookLM

Editor in Chief's Top Pick 2025

About the journal:

(Polim Med) is a long-established scientific journal, published continuously since 1971. It is currently a semi-annual, peer-reviewed, open-access title, offering free and immediate access to high-quality research for the global scientific and medical community. As an independent, multidisciplinary platform, the journal provides a forum for exchanging scientific knowledge and clinical experience in the rapidly developing field of polymer-based medical technologies. It publishes original research articles (technical, analytical, experimental, and clinical), preliminary communications, and review papers on the design, development, and application of synthetic and natural polymers and advanced biomaterials. 

The journal’s growing international visibility is reflected in its current metrics — its CiteScore Tracker is now 4.5. The scope spans medicine and materials science, including pharmaceutics, biotechnology, veterinary science, chemical and physical sciences, with strong coverage of biochemistry, controlled drug delivery, pharmacology, dentistry, implantology, and bioengineering. We welcome interdisciplinary submissions translating polymer research into diagnostics, therapies, and patient care.

This material is based on the article:

Photodynamic therapy: Basics and new directions for clinical applications

Aneta Popiel-Kopaczyk1, Tomasz Stanisław Kręcicki2, Roksana Kozieł3

1. Division of Histology and Embryology, Department of Human Morphology and Embryology and from the Clinic of Paediatric and Infectious Diseases
2. Department of Otolaryngology, Head and Neck Surgery, Wroclaw Medical University, Poland
3. Institute of Internal Medicine, Wroclaw Medical University, Poland

Polymers in Medicine

DOI: 10.17219/pim/208132

Web. A. Maj

Photo: freepik.com, unsplash.com